PUBLISHER: IMARC | PRODUCT CODE: 1390658
PUBLISHER: IMARC | PRODUCT CODE: 1390658
The global human enhancement market size reached US$ 97.9 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 215.9 Billion by 2028, exhibiting a growth rate (CAGR) of 14.09% during 2022-2028.
Human enhancement refers to a natural, artificial, and technological alteration of the body to enhance cognitive and physical capabilities and functions of individuals. It is undertaken using drugs, hormones, implants, genetic engineering to dietary supplements and cosmetic surgeries for self-improvement. Nowadays, advances in human enhancement technologies provide resistance against diseases like malaria, tuberculosis, and Lyme. They also allow up-to-date diagnostic and advancements in genome editing technologies, such as clustered regularly interspaced short palindromic repeats (CRISPR) for a functional cure of human immunodeficiency virus (HIV) infection.
The growing prevalence of acute and chronic diseases, in confluence with the increasing access to healthcare services, represents one of the key factors positively influencing the demand for human enhancement technologies around the world. These technologies mainly include nanotechnology, information technology (IT), and cognitive science, which assist in upgrading biomedical interventions as well as diagnose and treat various diseases. They also comprise active control systems that help create limb prosthetics with characteristics that exceed human performance. Moreover, emerging technologies like genetic engineering, neuronal implants, brain-computer interfaces, and three-dimensional (3D) bioprinting are contributing to the market growth. Apart from this, due to rising geopolitical tension between countries, security agencies of several countries are investing in research programs to improve battlefield performance. For instance, the ethics committee in the French Army approved the research of human enhancement technologies for developing enhanced soldiers. This research also involves the utilization of advanced systems, ranging from drugs to exoskeletons, to enhance military personnel in targeting decisions. These factors are anticipated to drive the adoption of human enhancement technologies and influence the market positively in the coming years.
IMARC Group provides an analysis of the key trends in each sub-segment of the global human enhancement market report, along with forecasts at the global, regional and country level from 2023-2028. Our report has categorized the market based on product, device type and end user.
Exoskeleton
Smart Devices
Medical Devices
Implants
Others
Body Worn
Non-Body Worn
Healthcare
Defense
Information Technology
Others
North America
United States
Canada
Asia-Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa
The competitive landscape of the industry has also been examined along with the profiles of the key players being BrainGate, B-Temia Inc, Ekso Bionics, Google LLC, Magic Leap Inc, Raytheon Technologies Corporation, ReWalk Robotics Ltd, Samsung Electronics Co. Ltd., Second Sight Medical Products Inc. and Vuzix Corporation.